Gambogic acid is a novel anti-cancer agent that inhibits cell proliferation, angiogenesis and metastasis

Anti-Cancer Agents in Medicinal Chemistry

Volumn 12, Issue 8, 2012, Pages 994-1000

  Wang, Xu ^a   Chen, Wantao ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Angiogenesis; Anti cancer agents; Apoptosis; Gambogic acid; Metastasis; Natural product

Indexed keywords

CAFFEINE; CELASTROL; DOCETAXEL; EPIDERMAL GROWTH FACTOR; FLUOROURACIL; GAMBOGIC ACID; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PLATELET DERIVED GROWTH FACTOR; PROTEIN BCL 2; PROTEIN P53; STAT3 PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE; TENIPOSIDE; TRANSFERRIN RECEPTOR; TYROSINE KINASE RECEPTOR; VASCULOTROPIN;

ACUTE LYMPHOCYTIC LEUKEMIA; ANGIOGENESIS; APOPTOSIS; BILE DUCT CARCINOMA; BIRTH WEIGHT; BREAST CANCER; CANCER CELL; CELL ADHESION; CELL PROLIFERATION; CHILDHOOD CANCER; DNA DAMAGE; ENZYME INHIBITION; G2 PHASE CELL CYCLE CHECKPOINT; GLIOBLASTOMA; HIGH THROUGHPUT SCREENING; HUMAN; LEUKEMIA; LIVE BIRTH; LIVER CELL CARCINOMA; M PHASE CELL CYCLE CHECKPOINT; METASTASIS; NEOPLASM; NONHUMAN; OSTEOSARCOMA; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; SIDE EFFECT; STOMACH CANCER; UTERINE CERVIX CANCER;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOLOGICAL PRODUCTS; CELL PROLIFERATION; GARCINIA; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; XANTHONES;

EID: 84866382102     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/187152012802650066     Document Type: Review

References (57)

1. Blanc, R.; Espejo, T.; Lopez-Montes, A.; Torres, D.; Crovetto, G.; Navalon, A.; Vilchez, J.L. Sampling and identification of natural dyes in historical maps and drawings by liquid chromatography with diode-array detection. J.Chromatogr. A, 2006, 1122, 105-113.
2. Batova, A.; Lam, T.; Wascholowski, V.; Yu, A.L.; Giannis, A.; Theodorakis, E.A. Synthesis and evaluation of caged Garcinia xanthones. Org. Biomol. Chem., 2007, 5, 494-500.
3. Feng, F.; Liu, W.; Wang, Y.; Guo, Q.; You, Q. Structure elucidation of metabolites of gambogic acid in vivo in rat bile by high-performance liquid chromatography-mass spectrometry and high-performance liquid chromatography-nuclear magnetic resonance. J. Chromatogr.B Analyt. Technol. Biomed. Life Sci., 2007, 860, 218-226.
4. Feng, F.; Liu, W.Y.; Chen, Y.S.; Guo, Q.L.; You, Q.D. Five novel prenylated xanthones from Resina Garciniae. J. Asian Nat. Prod. Res., 2007, 9, 735-741.
5. Asano, J.; Chiba, K.; Tada, M.; Yoshii, T. Cytotoxic xanthones from Garcinia hanburyi. Phytochemistry, 1996, 41, 815-820.
6. Zhang, H.Z.; Kasibhatla, S.; Wang, Y.; Herich, J.; Guastella, J.; Tseng, B.; Drewe, J.; Cai, S.X. Discovery, characterization and SAR of gambogic acid as a potent apoptosis inducer by a HTS assay. Bioorg. Med. Chem., 2004, 12, 309-317.
7. Wang, Y.; Chen, Y.; Chen, Z.; Wu, Q.; Ke, W.J.; Wu, Q.L. Gambogic acid induces death inducer-obliterator 1-mediated apoptosis in Jurkat T cells. Acta Pharmacol. Sin., 2008, 29, 349-354.
8. Li, R.; Chen, Y.; Zeng, L.L.; Shu, W.X.; Zhao, F.; Wen, L.; Liu, Y. Gambogic acid induces G0/G1 arrest and apoptosis involving inhibition of SRC-3 and inactivation of Akt pathway in K562 leukemia cells. Toxicology, 2009, 262, 98-105.
9. Zhang, L.; Yi, Y.; Chen, J.; Sun, Y.; Guo, Q.; Zheng, Z.; Song, S. Gambogic acid inhibits Hsp90 and deregulates TNF-alpha/NF-kappaB in HeLa cells. Biochem. Biophys. Res. Commun., 2010, 403, 282-287.
10. Hahnvajanawong, C.; Boonyanugomol, W.; Nasomyon, T.; Loilome, W.; Namwat, N.; Anantachoke, N.; Tassaneeyakul, W.; Sripa, B.; Namwat, W.; Reutrakul, V. Apoptotic activity of caged xanthones from Garcinia hanburyi in cholangiocarcinoma cell lines. World J. Gastroenterol., 2010, 16, 2235-2243.
11. Mu, R.; Lu, N.; Wang, J.; Yin, Y.; Ding, Y.; Zhang, X.; Gui, H.; Sun, Q.; Duan, H.; Zhang, L.; Zhang, Y.; Ke, X.; Guo, Q. An oxidative analogue of gambogic acid-induced apoptosis of human hepatocellular carcinoma cell line HepG2 is involved in its anticancer activity in vitro. Eur. J. Cancer Prev., 2010, 19, 61-67.
12. Yang, Y.; Yang, L.; You, Q.D.; Nie, F.F.; Gu, H.Y.; Zhao, L.; Wang, X.T.; Guo, Q.L. Differential apoptotic induction of gambogic acid, a novel anticancer natural product, on hepatoma cells and normal hepatocytes. Cancer Lett., 2007, 256, 259-266.
13. Guo, Q.L.; You, Q.D.; Wu, Z.Q.; Yuan, S.T.; Zhao, L. General gambogic acids inhibited growth of human hepatoma SMMC-7721 cells in vitro and in nude mice. Acta Pharmacol. Sin., 2004, 25, 769-774.
14. Gu, H.; Rao, S.; Zhao, J.; Wang, J.; Mu, R.; Rong, J.; Tao, L.; Qi, Q.; You, Q.; Guo, Q. Gambogic acid reduced bcl-2 expression via p53 in human breast MCF-7 cancer cells. J. Cancer Res. Clin. Oncol., 2009, 135, 1777-1782.
15. Wang, T.; Wei, J.; Qian, X.; Ding, Y.; Yu, L.; Liu, B. Gambogic acid, a potent inhibitor of survivin, reverses docetaxel resistance in gastric cancer cells. Cancer Lett., 2008, 262, 214-222.
16. Zhao, L.; Guo, Q.L.; You, Q.D.; Wu, Z.Q.; Gu, H.Y. Gambogic acid induces apoptosis and regulates expressions of Bax and Bcl-2 protein in human gastric carcinoma MGC-803 cells. Biol. Pharm. Bull., 2004, 27, 998-1003.
17. Liu, W.; Guo, Q.L.; You, Q.D.; Zhao, L.; Gu, H.Y.; Yuan, S.T. Anticancer effect and apoptosis induction of gambogic acid in human gastric cancer line BGC-823. World J. Gastroenterol., 2005, 11, 3655-3659.
18. Qiang, L.; Yang, Y.; You, Q.D.; Ma, Y.J.; Yang, L.; Nie, F.F.; Gu, H.Y.; Zhao, L.; Lu, N.; Qi, Q.; Liu, W.; Wang, X.T.; Guo, Q.L. Inhibition of glioblastoma growth and angiogenesis by gambogic acid: an in vitro and in vivo study. Biochem. Pharmacol., 2008, 75, 1083-1092.
19. Zhao, W.; Zhou, S.F.; Zhang, Z.P.; Xu, G.P.; Li, X.B.; Yan, J.L. Gambogic acid inhibits the growth of osteosarcoma cells in vitro by inducing apoptosis and cell cycle arrest. Oncol. Rep., 2011, 25, 1289-1295.
20. Han, Q.; Yang, L.; Liu, Y.; Wang, Y.; Qiao, C.; Song, J.; Xu, L.; Yang, D.; Chen, S.; Xu, H. Gambogic acid and epigambogic acid, C-2 epimers with novel anticancer effects from Garcinia hanburyi. Planta Med., 2006, 72, 281-284.
21. Qin, Y.; Meng, L.; Hu, C.; Duan, W.; Zuo, Z.; Lin, L.; Zhang, X.; Ding, J. Gambogic acid inhibits the catalytic activity of human topoisomerase IIalpha by binding to its ATPase domain. Mol. Cancer Ther., 2007, 6, 2429-2440.
22. Yu, J.; Guo, Q.L.; You, Q.D.; Zhao, L.; Gu, H.Y.; Yang, Y.; Zhang, H.W.; Tan, Z.; Wang, X. Gambogic acid-induced G2/M phase cell-cycle arrest via disturbing CDK7-mediated phosphorylation of CDC2/p34 in human gastric carcinoma BGC-823 cells. Carcinogenesis, 2007, 28, 632-638.
23. Wang, J.; Liu, W.; Zhao, Q.; Qi, Q.; Lu, N.; Yang, Y.; Nei, F.F.; Rong, J.J.; You, Q.D.; Guo, Q.L. Synergistic effect of 5-fluorouracil with gambogic acid on BGC-823 human gastric carcinoma. Toxicology, 2009, 256, 135-140.
24. Huang, H.; Chen, D.; Li, S.; Li, X.; Liu, N.; Lu, X.; Liu, S.; Zhao, K.; Zhao, C.; Guo, H.; Yang, C.; Zhou, P.; Dong, X.; Zhang, C.; Guanmei; Dou, Q.P.; Liu, J. Gambogic acid enhances proteasome inhibitor-induced anticancer activity. Cancer Lett., 2011, 301, 221-228.
25. He, D.; Xu, Q.; Yan, M.; Zhang, P.; Zhou, X.; Zhang, Z.; Duan, W.; Zhong, L.; Ye, D.; Chen, W. The NF-kappa B inhibitor, celastrol, could enhance the anti-cancer effect of gambogic acid on oral squamous cell carcinoma. BMC Cancer, 2009, 9, 343.
26. Chen, B.; Liang, Y.; Wu, W.; Cheng, J.; Xia, G.; Gao, F.; Ding, J.; Gao, C.; Shao, Z.; Li, G.; Chen, W.; Xu, W.; Sun, X.; Liu, L.; Li, X.; Wang, X. Synergistic effect of magnetic nanoparticles of Fe(3)O(4) with gambogic acid on apoptosis of K562 leukemia cells. Int. J. Nanomedicine, 2009, 4, 251-259.
27. Wang, C.; Zhang, H.; Chen, B.; Yin, H.; Wang, W. Study of the enhanced anticancer efficacy of gambogic acid on Capan-1 pancreatic cancer cells when mediated via magnetic Fe(3)O(4) nanoparticles. Int. J. Nanomedicine, 2011, 6, 1929-1935.
28. Ortiz-Sanchez, E.; Daniels, T.R.; Helguera, G.; Martinez-Maza, O.; Bonavida, B.; Penichet, M.L. Enhanced cytotoxicity of an anti-transferrin receptor IgG3-avidin fusion protein in combination with gambogic acid against human malignant hematopoietic cells: functional relevance of iron, the receptor, and reactive oxygen species. Leukemia, 2009, 23, 59-70.
29. Pandey, M.K.; Sung, B.; Ahn, K.S.; Kunnumakkara, A.B.; Chaturvedi, M.M.; Aggarwal, B.B. Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-kappaB signaling pathway. Blood, 2007, 110, 3517-3525.
30. Gu, H.; Wang, X.; Rao, S.; Wang, J.; Zhao, J.; Ren, F.L.; Mu, R.; Yang, Y.; Qi, Q.; Liu, W.; Lu, N.; Ling, H.; You, Q.; Guo, Q. Gambogic acid mediates apoptosis as a p53 inducer through down-regulation of mdm2 in wild-type p53-expressing cancer cells. Mol. Cancer Ther., 2008, 7, 3298-3305.
31. Rong, J.J.; Hu, R.; Qi, Q.; Gu, H.Y.; Zhao, Q.; Wang, J.; Mu, R.; You, Q.D.; Guo, Q.L. Gambogic acid down-regulates MDM2 oncogene and induces p21(Waf1/CIP1) expression independent of p53. Cancer Lett., 2009, 284, 102-112.
32. Rong, J.J.; Hu, R.; Song, X.M.; Ha, J.; Lu, N.; Qi, Q.; Tao, L.; You, Q.D.; Guo, Q.L. Gambogic acid triggers DNA damage signaling that induces p53/p21(Waf1/CIP1) activation through the ATR-Chk1 pathway. Cancer Lett, 2010, 296, 55-64.
33. Alsafadi, S.; Tourpin, S.; Andre, F.; Vassal, G.; Ahomadegbe, J.C. P53 family: at the crossroads in cancer therapy. Curr. Med. Chem., 2009, 16, 4328-4344.
34. Wang, J.; Zhao, Q.; Qi, Q.; Gu, H.Y.; Rong, J.J.; Mu, R.; Zou, M.J.; Tao, L.; You, Q.D.; Guo, Q.L. Gambogic acid-induced degradation of mutant p53 is mediated by proteasome and related to CHIP. J. Cell Biochem., 2010, 112, 509-519.
35. Davenport, J.; Manjarrez, J.R.; Peterson, L.; Krumm, B.; Blagg, B.S.; Matts, R.L. Gambogic acid, a natural product inhibitor of Hsp90. J. Nat. Prod., 2011, 74, 1085-1092.
36. Kajiro, M.; Hirota, R.; Nakajima, Y.; Kawanowa, K.; So-ma, K.; Ito, I.; Yamaguchi, Y.; Ohie, S.H.; Kobayashi, Y.; Seino, Y.; Kawano, M.; Kawabe, Y.; Takei, H.; Hayashi, S.; Kurosumi, M.; Murayama, A.; Kimura, K.; Yanagisawa, J. The ubiquitin ligase CHIP acts as an upstream regulator of oncogenic pathways. Nat. Cell Biol., 2009, 11, 312-319.
37. Kasibhatla, S.; Jessen, K.A.; Maliartchouk, S.; Wang, J.Y.; English, N.M.; Drewe, J.; Qiu, L.; Archer, S.P.; Ponce, A.E.; Sirisoma, N.; Jiang, S.; Zhang, H.Z.; Gehlsen, K.R.; Cai, S.X.; Green, D.R.; Tseng, B. A role for transferrin receptor in triggering apoptosis when targeted with gambogic acid. Proc. Natl. Acad. Sci. USA, 2005, 102, 12095-12100.
38. Jian, J.; Yang, Q.; Huang, X. SRC regulates tyr20 phosphorylation of transferrin receptor-1 and potentiates breast cancer cell survival. J. Biol. Chem., 2011, 286, 35708-35715.
39. Zhu, X.; Zhang, H.; Lin, Y.; Chen, P.; Min, J.; Wang, Z.; Xiao, W.; Chen, B. Mechanisms of gambogic acid-induced apoptosis in non-small cell lung cancer cells in relation to transferrin receptors. J. Chemother., 2009, 21, 666-672.
40. Zhao, Q.; Yang, Y.; Yu, J.; You, Q.D.; Zeng, S.; Gu, H.Y.; Lu, N.; Qi, Q.; Liu, W.; Wang, X.T.; Guo, Q.L. Posttranscriptional regulation of the telomerase hTERT by gambogic acid in human gastric carcinoma 823 cells. Cancer Lett., 2008, 262, 223-231.
41. Yu, J.; Guo, Q.L.; You, Q.D.; Lin, S.S.; Li, Z.; Gu, H.Y.; Zhang, H.W.; Tan, Z.; Wang, X. Repression of telomerase reverse transcriptase mRNA and hTERT promoter by gambogic acid in human gastric carcinoma cells. Cancer Chemother. Pharmacol., 2006, 58, 434-443.
42. Guo, Q.L.; Lin, S.S.; You, Q.D.; Gu, H.Y.; Yu, J.; Zhao, L.; Qi, Q.; Liang, F.; Tan, Z.; Wang, X. Inhibition of human telomerase reverse transcriptase gene expression by gambogic acid in human hepatoma SMMC-7721 cells. Life Sci., 2006, 78, 1238-1245.
43. Wu, Z.Q.; Guo, Q.L.; You, Q.D.; Zhao, L.; Gu, H.Y. Gambogic acid inhibits proliferation of human lung carcinoma SPC-A1 cells in vivo and in vitro and represses telomerase activity and telomerase reverse transcriptase mRNA expression in the cells. Biol. Pharm. Bull., 2004, 27, 1769-1774.
44. Konnikova, L.; Simeone, M.C.; Kruger, M.M.; Kotecki, M.; Cochran, B.H. Signal transducer and activator of transcription 3 (STAT3) regulates human telomerase reverse transcriptase (hTERT) expression in human cancer and primary cells. Cancer Res., 2005, 65, 6516-6520.
45. Stefanou, N.; Papanikolaou, V.; Furukawa, Y.; Nakamura, Y.; Tsezou, A. Leptin as a critical regulator of hepatocellular carcinoma development through modulation of human telomerase reverse transcriptase. BMC Cancer, 2011, 10, 442.
46. Prasad, S.; Pandey, M.K.; Yadav, V.R.; Aggarwal, B.B. Gambogic Acid Inhibits STAT3 Phosphorylation through Activation of Protein Tyrosine Phosphatase SHP-1: Potential Role in Proliferation and Apoptosis. Cancer Prev. Res. (Phila), 2011, 4, 1084-1094.
47. Zhai, D.; Jin, C.; Shiau, C.W.; Kitada, S.; Satterthwait, A.C.; Reed, J.C. Gambogic acid is an antagonist of antiapoptotic Bcl-2 family proteins. Mol. Cancer Ther., 2008, 7, 1639-1646.
48. Cai, S.X.; Drewe, J.; Kasibhatla, S. A chemical genetics approach for the discovery of apoptosis inducers: from phenotypic cell based HTS assay and structure-activity relationship studies, to identification of potential anticancer agents and molecular targets. Curr. Med. Chem., 2006, 13, 2627-2644.
49. Yi, T.; Yi, Z.; Cho, S.G.; Luo, J.; Pandey, M.K.; Aggarwal, B.B.; Liu, M. Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signaling. Cancer Res., 2008, 68, 1843-1850.
50. Cao, L.; Liu, H.; Lam, D.S.; Yam, G.H.; Pang, C.P. In vitro screening for angiostatic potential of herbal chemicals. Invest. Ophthalmol. Vis. Sci., 2010, 51, 6658-6664.
51. Lu, N.; Yang, Y.; You, Q.D.; Ling, Y.; Gao, Y.; Gu, H.Y.; Zhao, L.; Wang, X.T.; Guo, Q.L. Gambogic acid inhibits angiogenesis through suppressing vascular endothelial growth factor-induced tyrosine phosphorylation of KDR/Flk-1. Cancer Lett., 2007, 258, 80-89.
52. Gerstner, E.R.; Duda, D.G.; di Tomaso, E.; Ryg, P.A.; Loeffler, J.S.; Sorensen, A.G.; Ivy, P.; Jain, R.K.; Batchelor, T.T. VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer. Nat. Rev. Clin. Oncol., 2009, 6, 229-2236.
53. Liu, Y.; Li, W.; Ye, C.; Lin, Y.; Cheang, T.Y.; Wang, M.; Zhang, H.; Wang, S.; Zhang, L.; Wang, S. Gambogic acid induces G0/G1 cell cycle arrest and cell migration inhibition via suppressing PDGF receptor beta tyrosine phosphorylation and Rac1 activity in rat aortic smooth muscle cells. J. Atheroscler. Thromb., 2010, 17, 901-913.
54. Palempalli, U.D.; Gandhi, U.; Kalantari, P.; Vunta, H.; Arner, R.J.; Narayan, V.; Ravindran, A.; Prabhu, K.S. Gambogic acid covalently modifies IkappaB kinase-beta subunit to mediate suppression of lipopolysaccharide-induced activation of NF-kappaB in macrophages. Biochem. J., 2009, 419, 401-409.
55. Qi, Q.; Gu, H.; Yang, Y.; Lu, N.; Zhao, J.; Liu, W.; Ling, H.; You, Q.D.; Wang, X.; Guo, Q. Involvement of matrix metalloproteinase 2 and 9 in gambogic acid induced suppression of MDA-MB-435 human breast carcinoma cell lung metastasis. J. Mol. Med. (Berl), 2008, 86, 1367-1377.
56. Li, C.; Lu, N.; Qi, Q.; Li, F.; Ling, Y.; Chen, Y.; Qin, Y.; Li, Z.; Zhang, H.; You, Q.; Guo, Q. Gambogic acid inhibits tumor cell adhesion by suppressing integrin beta1 and membrane lipid rafts-associated integrin signaling pathway. Biochem. Pharmacol., 2011, 82, 1873-1883.
57. Zhao, L.; Zhen, C.; Wu, Z.; Hu, R.; Zhou, C.; Guo, Q. General pharmacological properties, developmental toxicity, and analgesic activity of gambogic acid, a novel natural anticancer agent. Drug Chem. Toxicol., 2010, 33, 88-96.